類風濕性關節炎診斷檢測市場：依檢測類型、最終用戶和地區分類

Rheumatoid Arthritis Diagnostic Tests Market By Test Type (Serology Test, Monitoring RA Treatment Efficiency Tests ), By End User, By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年類風濕性關節炎診斷測試市場規模預計為32.554億美元，預計2033年將達到47.671億美元。預計2026年至2033年，該市場將以5.6%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	32.554億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	5.60%	預計金額（2033 年）	47.671億美元

類風濕性關節炎(RA) 是一種自體免疫發炎疾病。這意味著免疫系統會錯誤地攻擊體內健康的細胞，導致受累部位出現發炎（疼痛腫脹）。 RA 主要侵襲關節，通常會同時影響多個關節。 RA 常見於手、腕和膝關節。在受 RA 影響的關節中，關節內膜會發生炎症，損傷關節組織。這種組織損傷會導致長期或慢性疼痛、關節不穩定（失去平衡）和畸形。 RA 也會影響身體的其他組織，可能導致肺、心臟和眼睛等器官出現問題。類風濕性關節炎是自體免疫疾病，由免疫系統攻擊健康的身體組織所引起。類風濕性關節炎診斷檢測市場因其自身特性而呈現一定的細分程度，多家公司在全球和區域範圍內開展業務。

市場動態

主要市場參與企業正專注於採用內生成長策略，例如推出類風濕性關節炎血液診斷測試，這推動了全球類風濕性關節炎診斷測試市場的成長。例如，2020年3月，醫療技術公司BD（貝克頓·迪金森公司）和總部位於北卡羅來納州的私人臨床診斷公司BioMedomics宣布推出一種新型即時檢測（POC）產品，該產品可檢測血液中的抗體，以確認當前或既往是否感染過類風濕性關節炎。該測試僅需15分鐘即可出結果，並已在美國和中國的多家醫院和臨床實驗室進行了臨床驗證。

本報告的主要特點

本報告對全球類風濕性關節炎診斷檢測市場進行了詳細分析，以2025年為基準年，預測了2026年至2033年期間的市場規模和複合年成長率（CAGR）。報告也指出了各細分市場的潛在商機，並探討了該市場一系列具有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）介紹全球類風濕性關節炎診斷測試市場的主要公司。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球類風濕性關節炎診斷測試市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球類風濕性關節炎診斷測試市場中使用的各種策略矩陣來促進決策。

公司簡介
- Abbott Diagnostics（Abbott Laboratories）
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB, F.
- Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC（imaware）
- Svar Life Science AB
- Thermo Fisher Scientific Inc.

第9章

參考
分析方法

簡介目錄

Product Code: CMI3716

Rheumatoid Arthritis Diagnostic Tests Market is estimated to be valued at USD 3,255.4 Mn in 2026 and is expected to reach USD 4,767.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,255.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.60%	2033 Value Projection:	USD 4,767.1 Mn

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease, which means that your immune system attacks healthy cells in your body by mistake, causing inflammation (painful swelling) in the affected parts of the body. RA mainly attacks the joints, usually many joints at once. RA commonly affects joints in the hands, wrists, and knees. In a joint with RA, the lining of the joint becomes inflamed, causing damage to joint tissue. This tissue damage can cause long-lasting or chronic pain, unsteadiness (lack of balance), and deformity (misshapenness).RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart, and eyes.Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. The rheumatoid arthritis diagnostic tests market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally.

Market Dynamics

The key market players are focusing on adoption of growth organic strategies such launching of diagnostic blood test for rheumatoid arthritis, which is attributed to the growth of global rheumatoid arthritis diagnostic tests market. For instance, in March 2020, BD (Becton, Dickinson and Company) is a medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to rhumetoid arthritis in as little as 15 minutes test has been clinically validated at several hospitals and clinical laboratories in both the U.S. and China.

Key features of the study:

This report provides an in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2026-2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global rheumatoid arthritis diagnostic tests market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Abbott Diagnostics (Abbott Laboratories), Labcorp ,Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Augurex Life Sciences Corp., Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global rheumatoid arthritis diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
Serology Test
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
Monitoring RA Treatment Efficiency Tests
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
Global Rheumatoid Arthritis Diagnostic Tests Market, By End User (Revenue, USD Mn, 2021 - 2033)
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Global Rheumatoid Arthritis Diagnostic Tests, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Abbott Diagnostics (Abbott Laboratories) *
Labcorp
Antibodies Inc.
Networks LLC
Beckman Coulter, Inc.
Euro Diagnostica AB
F. Hoffmann-La Roche Ltd.
Qiagen NV
Siemens Healthcare GmbH
Augurex Life Sciences Corp.
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Exagen Inc.
Genway Biotech, Inc.
Microdrop LLC (imaware)
Svar Life Science AB
Thermo Fisher Scientific Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
Key Developments
PEST Analysis

4. Global Rheumatoid Arthritis Diagnostic Tests Market

Economic Impact
Impact on Supply and Demand

5. Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
  - Erythrocyte Sedimentation Rate (ESR)
  - Rheumatoid Factor (RF)
  - Anti-cyclic Citrullinated Peptide (anti-CCP)
  - Antinuclear Antibody (ANA)
  - Uric Acid
  - Other Tests
Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test

6. Global Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)

7. Global Rheumatoid Arthritis Diagnostic Tests Market, By Regions, 2021 €" 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Labcorp
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Antibodies Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Networks LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Beckman Coulter, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Euro Diagnostica AB, F.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hoffmann-La Roche Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Qiagen NV
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Siemens Healthcare GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Augurex Life Sciences Corp.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bio Rad Laboratories Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Exagen Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genway Biotech, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Microdrop LLC (imaware)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Svar Life Science AB
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies